Nasdaq:US$18.41 (+0.16) | HKEX:HK$30.45 (+1.15) | AIM:£3.00 (+0.1)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China